Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

What Shares Were Popular Last Week? Argo Blockchain, John Laing And More

Published 09/05/2021, 08:44
Updated 02/09/2020, 07:05

Here is a list of companies that were popular on the site in the latest week.

Argo Blockchain

UK listed cryptocurrency miner Argo Blockchain (LON:ARB) was popular after the company announced its April mining figures. The company said it mined 163 Bitcoins in April, down slightly from 165 in March. Shares opened the week at 192.5p before hitting a high of 200p on Tuesday. Shares closed the week at 172p.

Argo Blockchain

John Laing

John Laing Group (LON:JLG) was popular on the site after the company announced it was in discussions with KKR to be taken over. Shares opened the week 315.00p before rallying almost 20% on Thursday after the news broke to a high of 387.00p. Shares retreated slightly on Friday to close at 364.00p.

John Laing

Omega Diagnostics

UK based Omega Diagnostics (LON:ODX) announced positive data for its Mologix Covid-19 lateral flow antigen test. Omega Diagnostics shares opened the week at 71.25p before rallying to close the week near its weekly high at 84.00p.

Omega Diagnostics

Uber

Uber (NYSE:UBER) has been in the news after the company partnered with electric vehicle manufacturer Arrival. Separately, the company’s business model has come under threat in the US after the Biden administration’s new labour secretary signalled his intent to look more closely at the classification of gig economy workers. Uber shares opened the week at $55.12 but retreated throughout the week. On Thursday, shares hit a low of $45.74 before closing slightly off the lows at $47.03.

Uber

AstraZeneca (NASDAQ:AZN)

AstraZeneca (LON:AZN) shares were in focus as the Covid-19 vaccine maker continues to grab headlines. On Friday, the UK recommended that people under the age of 40 receive a different jab to AstraZeneca’s due to the risk of blood clots, some of which have been fatal. AstraZeneca shares opened the week at 7,828p and traded mixed throughout the week before closing at 7,735p on Friday.  

AstraZeneca

Latest comments

Thanks you Sir. Good job. see u later
alligator
In a while.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.